ACARIX AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0321 EUR | +3.22% |
|
+44.59% | +111.18% |
| 11/06 | Acarix Announces Enrollment of First Patient in Us-Based Clinical Workflow Evaluation Study | CI |
| 27/05 | Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Medical Diagnostic & Testing Equipment
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 14.75B | ||||||
| 2.22B | - | |||||
| 1.82B | - | - | ||||
| 1.43B | ||||||
| 1.23B |
